Reydin x 30

Reydin is a combination medication used for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg (77 lbs). It contains three active ingredients: Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir. Each of these ingredients has a specific role in managing HIV infection.

1. Lamivudine: Lamivudine belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs). It works by inhibiting the reverse transcriptase enzyme, which is necessary for the replication of the HIV virus. By blocking this enzyme, lamivudine helps to reduce the viral load and slows down the progression of HIV infection.
2. Tenofovir Disoproxil Fumarate: Tenofovir disoproxil fumarate is also an NRTI. It works similarly to lamivudine by interfering with the reverse transcriptase enzyme, thus inhibiting the replication of the HIV virus.
3. Dolutegravir: Dolutegravir is an integrase strand transfer inhibitor (INSTI). It blocks the integrase enzyme, which is responsible for integrating the viral genetic material into the DNA of the host immune cells. By inhibiting this process, dolutegravir prevents the replication of the HIV virus.

Dosage and Administration:

The recommended dosage of Reydin for adults and pediatric patients weighing at least 35 kg is one tablet taken orally once daily with or without food. The tablet should be swallowed whole and not crushed or chewed.

It is crucial to follow the prescribed dosage and schedule provided by your healthcare provider. Do not alter the dose or stop taking Reydin without consulting your doctor, as it may lead to reduced effectiveness and the development of drug resistance.

Precautions:

Before starting Reydin, inform your healthcare provider about any pre-existing medical conditions, including kidney problems, liver disease, or any allergies. It is essential to disclose all other medications, including over-the-counter drugs, supplements, and herbal products, as they may interact with Reydin.

While Reydin is effective in treating HIV-1 infection, it is not a cure for HIV/AIDS. Therefore, it is important to practice safe sex and take other necessary precautions to prevent the transmission of the virus to others.

Possible Side Effects:

Reydin may cause side effects in some individuals. Common side effects include nausea, diarrhea, headache, fatigue, insomnia, and abnormal dreams. Contact your healthcare provider if these side effects persist or worsen over time.

In rare cases, Reydin may cause severe side effects, such as allergic reactions, liver problems, or changes in kidney function. Seek immediate medical attention if you experience symptoms such as rash, yellowing of the skin or eyes, dark urine, abdominal pain, or signs of kidney dysfunction (changes in urination frequency, color, or volume).

In conclusion, Reydin is a combination medication containing Lamivudine, Tenofovir Disoproxil Fumarate, and Dolutegravir. It is used for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg. It is important to take Reydin as prescribed by your healthcare provider and follow all precautions and instructions. If you experience any concerning side effects, contact your doctor promptly.